Funding round
AdvanCell Series C
AdvanCell, which works in radiopharmaceutical development and manufacturing in Sydney, raised $178M in a Series C round announced on 13 Feb 2025. It is AdvanCell's second venture round on record; the one before was a Series B in Aug 2022.
$178M
Amount raised
Not disclosed
Post-money valuation
Valuation
What this round says about the price
AdvanCell did not disclose a valuation in this round. It came 30 months after AdvanCell's Series B. It is 35% of the $505M AdvanCell has raised in the venture rounds on record. AdvanCell raised again 17 months later: a Series D round of $315M in Jul 2026.
Comparable rounds
How it compares
30 Series C rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $74M, and this round was 2.4 times the median. The closest in time, other companies' Series C rounds in Pharmaceutical Products:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Abcuro Pharmaceutical Products | 12 Feb 2025 | $200M | not disclosed | New Enterprise Associates |
| Pharmaceutical Products | 14 Jan 2025 | $100M | $800M | Double Point Ventures and DCVC |
| Pharmaceutical Products | 24 Mar 2025 | $29M | not disclosed | not named |
| Pharmaceutical Products | 11 Dec 2024 | $120M | not disclosed | Bain Capital Life Sciences |
| Pharmaceutical Products | 16 Apr 2025 | $115M | not disclosed | CTI Life Sciences Fund and Advent Life Sciences |
| Pharmaceutical Products | 20 Dec 2024 | $42M | not disclosed | M&G Investments |
| Pharmaceutical Products | 20 Dec 2024 | $16M | not disclosed | Iberis Capital |
| Pharmaceutical Products | 30 May 2025 | $26M | not disclosed | National Reconstruction Fund Corporation |
Sources
Where this comes from
Reported by 3 sources.
Questions
Frequently asked
How much did AdvanCell raise in its Series C round?
AdvanCell raised $178M in its Series C round, announced in Feb 2025.
What was AdvanCell's valuation at the Series C round?
It was not disclosed.
How does it compare with other Series C rounds in Pharmaceutical Products?
30 Series C rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $74M, and this round was 2.4 times the median.
Did AdvanCell raise again after this round?
Yes: a Series D round in Jul 2026 of $315M.